Sign Up to like & get
recommendations!
1
Published in 2022 at "Life"
DOI: 10.3390/life13010043
Abstract: Cardiac hypertrophy is an early hallmark during the clinical course of heart failure. Therapeutic strategies aiming to alleviate cardiac hypertrophy via the mitogen-activated protein kinase (MAPK)/calcineurin-nuclear factor of activated T-cells (NFAT) signaling pathway may help…
read more here.
Keywords:
cardiomyocyte hypertrophy;
hypertrophy;
calcineurin;
empty pod ... See more keywords